Veterinary Applications

Ear infections with Pseudomonas are not unique to humans. Infections of animals are also a significant issue.

The market for veterinary medicines is worth over $11 billion per annum. The most rapid growth is in the sale of medicines for companion animals. Ear infections (otitis externa) in dogs are common. Pseudomonas aeruginosa accounts for a substantial proportion of canine otitis and tends to result in a chronic infection with antibiotic resistant strains. It is these chronic infections that provide the initial target for treatment, and where a successful field trial has already been conducted against well established, antibiotic-resistant infections. Based on this successful trial, the company has had discussions with potential partners for the development of a specific veterinary formulation.